trending Market Intelligence /marketintelligence/en/news-insights/trending/2ctqDdwshbMqlPoU6O1wYw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Obalon Therapeutics signs agreements with PE firms to raise up to $30M

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Obalon Therapeutics signs agreements with PE firms to raise up to $30M

Obalon Therapeutics Inc. signed two separate financing agreements with private equity firms to raise up to $30 million.

The Carlsbad, Calif.-based medical device maker inked an agreement with Chicago-based Lincoln Park Capital LLC under which the private equity firm will buy up to $20 million worth of shares over three years.

In addition, Obalon entered an at-the-market equity offering sales agreement with Boston's Canaccord Genuity LLC, a unit of Canada-based Canaccord Genuity Group Inc., under which the company will sell, from time to time, shares worth up to $10 million.

Obalon develops and commercializes medical devices, including a swallowable, gas-filled balloon system, to treat obesity.